Methotrexate 150 mg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 150 mg
Reference Brands:
Category: Arthritis
Injection contains methotrexate. It is used to treat severe psoriasis, and rheumatoid arthritis. In higher doses, methotrexate is used to treat cancer. Psoriasis is a skin disease that causes red, scaly patches, most commonly on the knees, elbows, and scalp. Arthritis is tenderness and swelling of one or more joints.
Product Description: Talk to your doctor if you have gastrointestinal disorders, liver problems, kidney problems, vaccinated recently, build-up of fluid in the lining of lungs or abdomen, infection, or if you are receiving radiotherapy before taking this medicine. Talk to your doctor if you are on a salt-controlled diet.
Methotrexate — third party manufacturing & bulk supply
Methotrexate 150 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Methotrexate is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Methotrexate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Methotrexate →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Pegloticase Injecatble
Strength:
8 mg/1.2 mL vial
Form: Injectable (IV solution)
Reference Brands: Krystexxa (US)
View Details
Febuxostat Tablets
Strength:
40 mg, 80 mg
Form: Oral Tablets
Reference Brands: Uloric(EU & US)
View Details
Allopurinol Tablets
Strength:
100 mg, 300 mg
Form: Oral Tablets
Reference Brands: Aloprim(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
